Join the DDA or

CQC shares learning from medicines inspections

Six areas of risk identified

June 11th 2019

Tagged: Clinical Zone news Dispensary guidance news

By Ailsa Colquhoun

The CQC has published a report sharing the learning from risks and good practice in medicines arising from inspections.

The report highlights six areas of risk that are common to all providers:

  • Prescribing, monitoring & reviewing
  • Administration
  • Transfer of care
  • Reporting & learning from incidents
  • Supply, storage & disposal
  • Staff competence & workforce capacity

The key recommendations for providers, including GPs, are:

  • Monitoring of high-risk medicines, regularly auditing adherence to national guidance such as NICE guidelines, and updating prescribing following national patient safety alerts. Ideally use prescribing software. High risk medicines include: insulin, ACE inhibitors, anticoagulants, methotrexate and lithium
  • Systems and processes to enable accurate and timely changes to prescriptions for example, when patients are discharged from hospital and after reviews for patients with long-term conditions
  • Assessment of stock of emergency medicines, with regular expiry checks and, readily accessible in an emergency
  • Closer working with pharmacy professionals to focus on medicines optimisation
  • Learn from medicines incidents. Reporting should be consistent with statutory notifications as appropriate, with a good process to review and discuss significant events.

For all the latest news of the 2020 DDA annual conference...

Learn more